Abstract
Head and neck squamous cell carcinomas (HNSCC) are malignant neoplasia with a high incidence worldwide, which is about 890,000 people affected annually. Approximately 450,000 deaths in the world yearly are a consequence of this devastating disease. The treatment, however, still suffers significantly from no specificity. Proteases, in general, play a relevant role in the transformation and…